Community Pharmacy England News

- 8TH MARCH 2024
- 0 COMMENTS
Improved prices for Mometasone 50micrograms/dose nasal spray and other products for February 2024
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has re-determined the February 2024 concessionary prices for the following medicines: Drug Pack size Price concession for February 2024 Baclofen 10mg tablets 84 £4.33 (previously £2.78) Etoricoxib 90mg tablets 28 £18.17 (previously £12.52) Mometasone
Read more
- Community Pharmacy England News
- 8TH MARCH 2024
- 0 COMMENTS
Celebrating International Women’s Day
Pharmacy Press Today, on International Women’s Day, we’re celebrating the achievements of women in community pharmacy. Embracing the theme “Inspire Inclusion”, we appreciate the contributions of women from various backgrounds, representing diverse communities who contribute significantly to our sector. We recognise also that there is potential to increase the representation and influence of women in
Read more
- Community Pharmacy England News
- 8TH MARCH 2024
- 0 COMMENTS
GPhC addresses Racism and Language Barriers in Pharmacy with new reports
The General Pharmaceutical Council (GPhC) has published new reports on racism and inequalities in pharmacy, following virtual equality discussions held with various key stakeholders. The reports, titled Racism in Pharmacy: Accountability Counts and Language Barriers and Health Inequalities, were derived from a series of virtual equality roundtables and shaped by input from pharmacy professionals and
Read more
- Community Pharmacy England News
- 6TH MARCH 2024
- 0 COMMENTS
Medicine Supply Notification: Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials. This MSN supersedes the National Patient Safety Alert issued on 26 February 2024. MSN/2024/028 Tier 2 – medium impact Date of issue 6th March 2024 The supply position of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebules
Read more
- Community Pharmacy England News
- 6TH MARCH 2024
- 0 COMMENTS
Spring budget sets out NHS plans but brings no sign of relief for pharmacies
The Chancellor announced his Spring Budget today, against a backdrop of media speculation about whether a spring general election will soon be announced. The budget contained several measures, including: A 2p reduction in National Insurance contributions from 6th April. A plan for more efficient public services Tackling inflation and bringing down borrowing in Britain A
Read more
- Community Pharmacy England News
- 5TH MARCH 2024
- 0 COMMENTS
Pharmacy bodies launch manifesto ahead of next General Election
Community Pharmacy England, the Company Chemists’ Association, the National Pharmacy Association and the Royal Pharmaceutical Society have today (5th March) published a joint Manifesto for community pharmacy, ahead of the General Election expected this year. The manifesto can be used by anyone in the community pharmacy sector, including LPCs and all pharmacy owners, to engage
Read more
- Community Pharmacy England News
- 4TH MARCH 2024
- 0 COMMENTS
Pharmacy Pressures Survey 2024: We want to hear from you
Community Pharmacy England has launched its third annual Pressures Survey and we hope to hear directly from everyone who owns or works in a community pharmacy. The situation for community pharmacies is now critical and we know this is impacting on workload, stress levels, patients, and businesses. We want to hear more about this, and
Read more
- Community Pharmacy England News
- 4TH MARCH 2024
- 0 COMMENTS
Pharmacy First submission deadline extended after technical issue
The NHS Business Services Authority (NHSBSA) has confirmed that the deadline for pharmacy owners to make their claims for February Pharmacy First consultations has been extended until 5pm on Friday 15th March 2024. This is an extended deadline for February only (this includes any consultations completed on 31st January 2024) and it follows an issue
Read more
- Community Pharmacy England News
- 4TH MARCH 2024
- 0 COMMENTS
Medicine Supply Notification: Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-filled pens
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-filled pens. MSN/2024/027 Tier 2 – medium impact Date of issue: 4th March 2024 Fiasp® FlexTouch® (insulin aspart) 100units/ml pre-filled pens will be out of stock from April 2024 until January 2025.
Read more
- Community Pharmacy England News
- 1ST MARCH 2024
- 0 COMMENTS
Unlicensed Cefuroxime 5% eye drops preservative free – expense payment
From 1st March 2024, an additional fixed out-of-pocket expense payment of £50 will be automatically applied to NHS prescriptions for Cefuroxime 5% eye drops preservative free (a non-Drug Tariff special). Due to the unique temperature controlled transport and storage requirements of Cefuroxime 5% eye drops preservative free, significant delivery and handling charges are often incurred
Read more
- Community Pharmacy England News

Improved prices for Mometasone 50micrograms/dose nasal spray and other products for February 2024

Celebrating International Women’s Day

GPhC addresses Racism and Language Barriers in Pharmacy with new reports

Medicine Supply Notification: Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials

Spring budget sets out NHS plans but brings no sign of relief for pharmacies

Pharmacy bodies launch manifesto ahead of next General Election

Pharmacy Pressures Survey 2024: We want to hear from you

Pharmacy First submission deadline extended after technical issue

Medicine Supply Notification: Fiasp® FlexTouch® (insulin aspart) 100units/ml solution for injection 3ml pre-filled pens

Unlicensed Cefuroxime 5% eye drops preservative free – expense payment

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care